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Hemodynamic data were obtained in 13 cirrhotic patients with severe portal hypertension,
undergoing combined hepatic vein, umbilicoportal vein, and superior mesenteric artery
catheterization. The relative clearance of indocyanine green, the portohepatic gradient
(difference between the free portal venous pressure and the free hepatic venous pressure), and
the estimated hepatic blood flow were measured. The portal fraction (PF) of total hepatic
blood flow was calculated in all patients using indicator dilution curves obtained from the
portal bifurcation, a right hepatic vein, and when possible a left hepatic vein (six cases) after in-
jection of 5'Cr-labeled red blood cells (51Cr RBC) into the superior mesenteric artery. Flows
were overestimated because of loss of indicator through spontaneous portosystemic shunts;
however, the ratio between hepatic and portal indicator dilution curves can be used tocalculate
the portal fraction of total hepatic blood flow since no extrahepatic shunts existed after the
bifurcation of the portal vein (as shown on portography). In 10 patients, 15 series of curves
were calculable and the PF varied between 30.1 and 100% (mean i SE: 71.1 i 6.2%). In the
three other patients, only delayed activity from recirculation was detected from portal and he-
patic vein samples and PF was 0%; in these three cases, portography and arteriography
revealed spontaneous portacaval shunting with reverse and/or stagnant circulation in the
portal vein. In the 13 patients, no correlation existed between PF and the relative clearance of
indocyanine green or the portohepatic gradient, parameters generally used as indices of
severity in cirrhosis. In 10 patients, no correlation was found between PF and theestimated he-
patic blood flow.
These data indicate that 51Cr RBC dilution curves can be used for the estimation of the
portal fraction of total hepatic blood flow in conscious cirrhotic patients before portacaval
shunts. Using this methodology, it could be assessed whether any critical level of portal
fraction exists above which poor clinical results occur after portacaval shunting. This
measurement could eventually be helpful in determining the appropriate surgical procedure to
be applied in individual cases.
The importance of portal inflow in hepatic perfusion and function has never been
satisfactorily evaluated in awake man because ofthedoubleblood supply to the liver
and the relative inaccessibility of the portal vein. A nonsurgical method, which
would avoid anesthesia and dissection of vessels (as needed for the use of elec-
tromagnetic flowmeters), would be of great importance both physiologically and
clinically in quantitating the components of the hepatic circulation. Recently,
several indirect methods have been proposed for the separate measurement of he-
patic arterial and portal blood flows (1-10); however, most of these studies are not
based on an experimental model.
In a previous study, the use ofportal and hepatic indicator dilution curves, after
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injection of 51Cr-labeled red blood cells (5'Cr RBC) into the cranial mesenteric
artery, has been validated for the estimation ofportal blood flow, total hepatic blood
flow, and the portal fraction of total hepatic blood flow in normal dogs (11). This
technique was applied in 17 cirrhotic patients with severe portal hypertension under-
going combined umbilicoportal, hepatic vein and superior mesenteric artery
catheterization.
In cirrhotic patients, flows are overestimated because ofloss of an unknown part
of the indicator through spontaneous portosystemic collaterals. However, if no
extrahepatic shunts exist after the bifurcation oftheportal vein, the same amount of
indicator should be analyzed from the portal bifurcation and hepatic veins.
Therefore, even though absolute flow values cannot be calculated, the ratio between
the area ofhepatic and portal indicator dilution curves can be used to calculate the
portal fraction oftotal hepatic blood flow.
MATERIAL AND METHODS
Material
Seventeen cirrhotic patients with severe portal hypertension, 13 males and four fe-
males, aged 36-59 yr (mean: 49 yr), underwent a hemodynamic evaluation. At the
time of the study, none of these patients had ascites, peripheral edema, jaundice, or
alcoholic hepatitis. Diagnosis ofcirrhosis was confirmed by needle biopsy ofthe liver
in all patients: 16 of these patients had alcoholic cirrhosis. The relative clearance of
indocyanine green (K-ICG) (12) was measured the week before the hemodynamic
studies. Plasma disappearance curves for indocyanine green were obtained and the
disappearance rate constant was derived from the function:
P, =Pe -Kt,
where P, = plasma concentration ofdye at time t in minutes and P0 = plasma con-
centration of dye at time 0; the disappearance rate constant K, or K - 100, is the
fraction ofretained dye which is removed per minute.
In all patients, a portal catheterization via the round ligament of the liver was
performed (13) and retrograde splenography and portography were obtained using a
rapid film changer.
Hepatic vein(s) and superior mesenteric artery catheterizations were performed 2
days after portal catheterization, under fluoroscopic visualization, using minimal
amount ofradiopaque material (less than 20 ml).
In all patients, a right hepatic vein was cannulated through an antecubital vein of
one arm using a Cournand catheter (no. 8 or 9F). In six patients, a left hepatic vein
was cannulated through a femoral vein by the Seldinger technique using a precurved
polyethylene catheter (no. 8F). The superior mesenteric artery was then cannulated
through a femoral artery on the opposite side by the Seldinger technique using a
Cordis polyethylene catheter (Cordis Corporation, Miami). In two cases where a he-
patic artery originated from the superior mesenteric artery the arterial catheter was
advanced well into this artery beyond the takeoffofthehepatic artery.
Methods
(a) Pressures. Wedged hepatic vein pressure, free hepatic vein pressure, and free
portal vein pressure were recorded using a Statham gauge transducer with the
patient in a supine position (zero level assumed to be 5 cm below the sternal angle).
Each pressure was recorded on at least two occasions.
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FIG. 1. Schematic diagram illustrating the position ofthe injection and sampling catheters in man.
(b) Estimated hepatic bloodflow. Estimated hepatic blood flow was calculated
using Bradley's method using a constant infusion ofindocyaninegreen (14). Samples
were obtained simultaneously from hepatic and portal veins at4-min intervals for 20
min, after an equilibration period of 15 min.
(c) Portalfraction of total hepatic bloodflow. Before performing indicator di-
lution curves (IDC), the portal catheter was withdrawn and positioned at the bifur-
cation ofthe portal vein under fluoroscopy without using radiopaque material. After
a single injection of the indicator into the superior mesenteric artery, IDC were ob-
tained simultaneously from the bifurcation of the portal vein and from hepatic
vein(s) (Fig. 1). Indocyanine green was used to control the position ofvarious cathe-
ters by direct recording ofcurves on photographic paper (15). However, a 5'Cr RBC
suspension (250 uCi in 15 ml of autologous blood) prepared according to Wagner
(16) (with three washings) was chosen as the ideal indicator as it gives, after sudden
injection, a sharp peak, making iteasily dissociable from recirculation (11, 17).
After instantaneous injections of 5 ml of 51Cr RBC into the superior mesenteric
artery, the catheter was flushed with blood or saline. Known volumes (0.4 ml) ofthe
same suspension counted on the automated gamma counter (Nuclear Chicago) were
used as standards. Samples were collected using a peristaltic pump (30 ml/min) into
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FIG. 2. Simultaneous indicator dilution curves (IDC) obtained from the portal vein (PV) and a right
hepatic vein (RHV) afterinjection of "lCr RBC into the superior mesenteric artery.
PF: portal fraction oftotalhepatic blood flow.
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FIG. 3. Simultaneous indicator dilution curves (IDC) obtained from the portal vein (PV) and a right
hepatic vein (RHV) after injection of5'Cr RBC into the superior mesenteric artery (first injection).
PF: portal fraction oftotal hepatic blood flow.
two or three serial collection racks with heparinized tubes, running at a speed ofone
tube per second. A standard volume (0.4 ml) was withdrawn from each tube,
counted separately, and results were plotted on semilogarithmic paper (Figs. 2 and
3). Extrapolation of the downslope to baseline, correction for background, ex-
pression of cpm per ml, and calculation of surface area were computed by a Wang
calculator (11).
The portal fraction oftotal hepatic blood flow was calculated by the ratio between
curve area simultaneously recorded from hepatic vein and portal vein. Twenty-two
(22) studies were performed in the 17 patients. In six studies (six patients), samples
were obtained simultaneously from one left and one righthepaticvein, and the mean
curve area measured from these two differenthepatic veins was used.
RESULTS
In four patients, complete hemodynamic data could not be obtained because of
technical difficulties: in two patients, hepatic vein samples could not be obtained be-
cause of clotting obstruction of the catheter; in one patient, portal samples could
not be obtained because the portal catheter was positioned in a narrow portal
branch; and finally, in one patient, the arterial catheter wasinadvertently withdrawn
from the superior mesenteric artery into the aorta just before the injection, as
verified by fluoroscopy. These four patients arenot included in thesedata.
In the 13 remaining patients, complete hemodynamic evaluation was obtained.
(a) Relative clearance ofindocyanine green (K-ICG). The K-ICG varied between
1.42 and 13.07% (mean i SE: 6.28 i 1.13%)(Table 1)(normal > 16%).
(b) Portohepatography. In all cases, portohepatography was obtained. In 10
cases, the coronary vein was dilated and tortuous with esophageal varices graded as
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TABLE 1
Data Obtained in 13 Cirrhotic Patients
Portohepatic Portal fraction of total
K-ICGb gradient E.H.B.F.C hepatic blood flow
Patient Age Sex (%) (mm Hg) (liters/min) (%)
I 44 F 3.02 13 1.00 73.4
II 54 M 4.77 13.5 2.69 83
III 58 M 11.55 12 2.16 81.3
IV 52 M 3.64 19 1.78 96
81
V 41 F 10.19 10 0.80 0
VI 55 M 10.26 11 1.07 d
VII 58 M 13.07 8 1.72 91.4
87
VIII 41 M 2.00 17 - 0
IX 57 M 10.19 17 1.60 38.1
30.1
X 36 M 4.45 19 1.24 100
XI 50 M 4.62 17 1.93 68.6d
57.7
XII 46 M 2.52 15 6.37 98.7
XIII 39 F 1.42 21 3.62 44d
37
aTwo IDC studies were performed in five cases (IV, VII, IX, XI, XIII).
bK-ICG: relative clearance ofindocyanine green.
cE.H.B.F.: estimatedhepatic blood flow (Bradley'smethod using indocyanine green).
dMean curve area obtained simultaneously from one right and one lefthepatic vein. The difference
between paired curve area was: 11% for patient VII, 7% for patient X, 12% for patient XI, and 30%
for patient XIII.
1+ to 4+ (13) but no extrahepatic shunts were demonstrated after the portal bifur-
cation. In three cases (V, VI, and VIII), large spontaneous portacaval shunting was
shown with reverse and/or stagnant flow in the portal vein (Figs. 4, 5), a finding sub-
sequently confirmed by arteriographies in all 3 cases.
(c) Pressures. The mean (±SE) free hepatic venous pressure was 11.8 ± 1.3
mmHg and varied between 6.5 and 24.5 mmHg. The mean wedged hepatic venous
pressure was 26.8 i 1.6 mmHg and varied between 17 and 38 mmHg. The mean free
portal venous pressure was 26.5 1.6 mmHg and varied between 19 and 38 mmHg.
The mean portohepatic gradient, or the difference between free portal venous
pressure and free hepatic venous pressure, was 14.8 ± 1.0 mmHg (8-21 mmHg) and
was used as an index ofthe portal hypertension (Table 1).
(d) Estimated hepatic bloodflow (EHBF). In 12 cases, EHBF could be estimated
and varied between 0.80 and 6.37 liters/min (mean: 2.16 + 1.54 liters/min).
However, in the two cases (XII and XIII) with high absolute values, the indocyanine
green extraction was less than 5% and the reliability ofthe constant-infusion method
is questionable (18). In one case (VIII), EHBF could not be estimated because there
were no differences in the ICG concentrations in hepatic and portal veins.
(e) Portalfraction oftotalhepatic bloodflow (PF). In 10 patients (I-IV, VII, and
IX-XIII), 15 series of IDC were calculable. PF varied from 30.1 to 100% (mean:
71.1 i 62%) (Table 1). In four of these patients (VII, X, XI, XIII), the mean
difference between paired curve areas calculated simultaneously from two hepatic
veins was 15.1 % (7-30%) (Table 1); (Figs. 2, 3).
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FIG. 4. Umbilicoportography showing the spontaneous portosplenorenal shunt with opacification of
the inferior vena cava (Patient VI).
In the other three patients (V, VI, VIII), in whom reverse and/or stagnant flow in
the portal vein was found on portography, only delayed activity from recirculation
was detected from portal and hepatic veins samples (Fig. 6). In these cases, PF was
0% (Table 1). In two of these patients (V, VI), samples were obtained si-
multaneously from two different hepatic veins.
In the 13 patients, no correlation existed between the portal fraction of total he-
patic blood flow and the K-ICG (r: -0.234, P > 0.1) or the portohepaticgradient (r:
0.356, P > 0.1). In the 10 patients in whom EHBF could be calculated and/or the in-
docyanine green extraction was more than 5%, no significant correlation existed be-
tween EHBF and PF (r: 0.535, P > 0.5).
In patient VIII, after injection of 5'Cr RBC into the superior mesenteric artery,
the arterial catheter was positioned into the hepatic artery under fluoroscopic vi-
sualization. Five milliliters of 5'Cr RBC were injected into the hepatic artery and
samples were simultaneously obtained from hepatic and portal veins. Similar IDC
were obtained (Fig. 7) from these two sampling sites, demonstrating a complete
inversion ofportal flow. Total hepatic blood flow could be estimated from these IDC
and was 2.0 liters/min using the portal IDC and 2.4 liters/min using the hepatic
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FIG. 5. Umbilicosplenographies from two different series showing: gastric and esophageal varices
originating from short gastric veins (a), reverse circulation into the inferior mesenteric vein with no
opacification of portal vein (a and b), and large hemorrhoidal shunt (b and c) with opacification ofthe in-
ferior vena cava (c) (Patient VIII).
IDC (difference: 17%) suggesting adequate mixing ofthe indicator within thehepatic
circulation.
DISCUSSION
The use ofportal and hepatic indicator dilution curves after injection of51Cr RBC
into the cranial mesenteric artery has been validated for theestimation ofportal and
total hepatic blood flows in normal dogs (11). With the introduction of portal
catheterization via the round ligament of the liver (19), a sampling site from the
portal vein is now available in man. Therefore, this technique can be applied to con-
scious cirrhotic patients with no surgical manipulation ofhepatic vessels and no cir-
culatory impairment to the liver.
In man, as in dogs, certain experimental conditions have to be fulfilled (11, 20, 21)
for the use ofthe indicator dilution method: (1) theindicator must be conserved, i.e.,
it must not be metabolized or excreted by the liver; (2) the same amount ofinjected
indicator must flow through the portal vein and the liver, i.e., there must be no loss
of the injected indicator through extrahepatic shunts after the bifurcation of the
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portal vein; (3) the indicator must be completely mixed with the blood studied at the
sampling sites in the portal vein and the hepatic vein(s); (4) sampling must be
representative of mixed portal and hepatic venous blood at the sampling sites; and
(5) the intrahepatic circulation must be in a steady state. In cirrhotic patients, loss
of an unknown part ofindicator through spontaneous portosystemic collaterals re-
sulted in overestimation of valves and absolute flows could not be calculated.
However, no extrahepatic shunts occurred after the portal bifurcation, as shown on
portography, and, therefore, the same amount of indicator was analyzed at the
bifurcation of the portal vein and in hepatic vein(s). Thus, the ratio between the
curve area obtained simultaneously from hepatic and portal veins can be used ac-
curately for the measurement ofthe portal fraction oftotal hepatic blood flow.
In normal dogs, adequate mixing of the indicator injected into the cranial
mesenteric artery was demonstrated in the portal vein (at least at its bifurcation) as
well as within the hepatic circulation (11). In man, although the phenomenon of
preferential lobar distribution of portal blood has never been clearly established, it
has, nevertheless, been popular clinical teaching to attribute localization of liver
metastases and abscesses to the selective distribution within the liver of blood flow
from the area ofthe primary tumor or infection (22, 23). So far, in four patients, the
differences found between the IDC obtained simultaneously from two different he-
patic veins varied between 7 and 30% (mean: 15.1%). Thesepreliminary findings sug-
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gest that when using this indicator dilution method, adequate mixing ofthe indicator
is achieved in the portal vein and thehepatic circulation in cirrhotic patients. Similar
findings have been reported in normal and cirrhotic patients after injection of 1311
albumin into the superior mesenteric or the splenic artery (24).
Ifconfirmed, these data indicate that the indicator dilution method reported here
can be used for the estimation of the portal fraction of total hepatic blood flow in
cirrhotic patients. This portal fraction oftotal hepatic blood flowdid not correlate in
the 13 patients with the K-ICG and the portohepatic gradient, parameters generally
used as indices ofseverity in cirrhosis.
This model can be applied also to study the behavior of substances removed from
blood by the reticuloendothelial cells (Kupffer cells) (25) or, possibly, by the
hepatocytes when compared to 5'Cr RBC injected in a same mixture and used as
vascular reference substance.
In conclusion, after a single injection of 5'Cr RBC into the superior mesenteric
artery, the portal fraction of hepatic blood flow can be estimated in conscious cir-
rhotic patients with portal hypertension. The measurement can be done without
anesthesia which reduces total hepatic blood flow and, presumably, portal flow (26)
and dissection ofhepatic vessels which modifies the portal fraction of total hepatic
blood flow in dogs (Huet et al, unpublished data). In patients with advanced cirrhosis
and portal hypertension, therapeutic portacaval shuntshave been shown to beeffica-
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FIG. 6. Activity recorded in samples obtained from the portal vein (PV-IDC), a right hepatic vein
(RHV-IDC), and a left hepatic vein (LHV-IDC) after injection of51Cr RBC into the superior mesenteric
artery in a patient with reverse circulation in the portal vein.
l, -PPATIENT #8
*-* * PV-IDC
0-(:)- HV - IDC
01
0
0
0
I0
0 5 10 15 20 25 30
TIME IN SECONDS
FIG. 7. Simultaneous indicator dilution curves obtained from the portal vein (PV) and one right he-
patic vein (HV) after injection ofCr51 red blood cells into the hepatic artery.
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cious in preventing recurrent variceal bleeding and to improve the 5-yr survival (27).
However, the long-term benefits of surgery are accompanied by higher mortality
due to early or progressive hepatic failure or other undesirable metabolic sequelae
such as encephalopathy (28). One ofthe consequences ofstandard portacaval shunts
is the loss of all portal blood flowing into the liver which can aggravate the hepatic
failure (29). So far, most of the splanchnic hemodynamic measurement generally
used in selection ofpatients for portal systemic shunts cannot be correlated with the
postoperative course. These include the wedged hepatic venous pressure or the free
portal vein pressure (30), the hepatic blood flow (30), the maximum perfusion
pressure (or the difference between pressure on the hepatic and splanchnic sides of a
clamp occluding the portal vein at surgery) (31) and even the absolute portal blood
flow (using electromagnetic flowmeters at surgery) (31). However, no study has been
performed adding to other hemodynamic parameters the measurement ofthe portal
fraction of hepatic blood flow. The methodology reported here can be applied in
awake patients before portacaval shunts. Thus, it can be assessed whether any
critical level of portal fraction exists above which poor clinical results occur after
portacaval shunting. Eventually, portacaval shunts could be reserved for patients
who have reduced portal fraction of total hepatic blood flow. In patients with high
portal fraction, arterialization oftheportal vein in association with portacaval shunt
may preserve hepatic blood flow while relieving portal hypertension (32).
ACKNOWLEDGMENTS
The authors thank G. Lachapelle, R. Boileau, and R. Huot for their technical assistance, M.
Desrochers for her medical art work, and J. Pruneau for his photographic work. The remarkable
assistance ofF. Duchesne in the preparation and typing ofthe manuscript isgratefully acknowledged.
REFERENCES
1. Chiandussi, L., Greco, F., Sardi, G., Vaccarino, A., Ferraris, C. M., and Curti, B. Estimation ofhe-
patic arterial and portal venous blood flow by direct catheterization of the vena porta through the
umbilical cord in man. Preliminary results. Acta Hepato-Splenol. 15, 166-171 (1968).
2. Curti, B., and Chiandussi, L. Estimation ofsegmental portal and splenic venous flow in man by retro-
grade catheterization ofthe vena porta via the umbilical cord. Preliminary report. Digestion 4, 141
(1971).
3. Marleau, D., Hoanca, O., Pointard, L., and Benhamou, J. P. A new method to assess separately
portal and hepatic arterial blood flow in dog and man. (abstract) Digestion 4, 163-164 (1971).
4. Katz, M. L., and Bergman, E. N. Simultaneous measurements of hepatic and portal venous blood
flow in the sheep and dog. Amer. J. Physiol. 216,946-952 (1969).
5. Stone, R. M., Tenhove, W., Effros, R., and Leevy, C. M. Portal venous blood flow: its estimation and
significance (abstract). Gastroenterology 62, 186 (1972).
6. Shizgal, H. M., and Goldstein, M. Measurement of portal and total hepatic blood flow by the intes-
tinal xenon technique. Surgery 72, 83-90 (1972).
7. Strandell, T., Erwald, R., Kulling, K. G., Lundbergh, P., Marions, O., and Wiechel, K. L. Si-
multaneous determination of portal vein and hepatic artery blood flow by indicator dilution tech-
nique in awake man. Aeta Med. Scand. 191, 139-140 (1972).
8. Reichle, F. A., Sovak, M., Soulen, R. L., and Rosemond, G. P. Portal vein blood flow determination
in the unanesthetized human by umbilicoportal cannulation.J. Surg. Res. 12, 146-150 (1972).
9. Ueda, H., Unuma, T., Iio, M., and Kameda, H. Measurement ofhepatic arterial and portal blood
flow and circulation time via hepatic artery and portal vein with radio-isotope. Jap. Heart J. 3,
154-166 (1962).
10. Nakamura, T., Nakamura, S., Aikawa, T., Kera, K., and Sasaki, K. Measurement of hepatic
arterial and portal venous blood flow in hepatic diseases. Angiology 22,46-54 (1971).
11. Huet, P. M., Lavoie, P., and Viallet, A. Simultaneous estimation ofhepatic and portal blood flows by
an indicator dilution technique.J. Lab. Clin. Med. 82, 836-846 (1973).66 HUET ET AL.
12. Caesar, J., Shaldon, S., Chiandussi, L., Guevera, L., and Sherlock, S. The use ofindocyanine green in
the measurement ofhepatic blood flow and as a test ofhepatic function. Clin. Sci. 21,43-57 (1961).
13. Lavoie, P., Jacob, M., Leduc, J., L6gar6, A., and Viallet, A. The umbilicoportal approach for the
study of splanchnic circulation: technical, radiological and hemodynamic considerations. Can. J.
Surg. 9, 338-343 (1966).
14. Leevy, C. M., Mendenhall, C. L., Lesko, W., and Howard, M. M. Estimation ofhepatic blood flow
with indocyanine green.J. Clin. Invest. 41, 1169-1179 (1962).
15. Huet, P. M., Lavoie, P., et Viallet, A. Application du principe des courbes de dilution d'un indicateur
a l'etude de la fraction portale du debit h6patique total. Union Med. Canada 101,656-665 (1972).
16. Wagner, H. N., Jr. Technical details of common procedures. In "Principles of Nuclear Medicine,"
(H. N. Wagner, Jr., Ed.), Chap. 1, pp. 832-858. Saunders, Philadelphia, 1968.
17. Goresky, C. A. A linear method fordetermining liver sinusoidal and extravascular volumes. Amer. J.
Physiol. 204,626-640 (1963).
18. Cohn, J. N., Khatri, J. M., Groszmann, R. S., and Kotelanski, B. Hepatic blood flow in alcoholic
liver disease measured by an indicator dilution technic. Amer. J. Med. 53, 704-714 (1972).
19. Gonzalez Carbalhaes, 0. Portography: a preliminary report ofa new technique via the umbilical vein.
Clin. Proc. Child. Hosp. 15,120-122 (1959).
20. Reichman, S., Davis, W. D., Storaasli, J. P., and Gorlin, R. Measurement ofhepatic blood flow by
indicator dilution techniques.J. Clin. Invest. 37, 1848-1856 (1958).
21. Shoemaker, W. C., Steenburg, R. W., Smith, L. L., and Moore, F. D. Experimental evaluation ofan
indicator dilution technique for estimation of hepatic blood flow. J. Lab. Clin. Med. 57, 661-670
(1961).
22. Berk, J. E., and Priest, R. J. Tumors of the liver. In "Gastroenterology," (H. L. Bockus, Ed.),
Volume III, pp. 502-529. Saunders, Philadelphia, 1965.
23. DeBakey, E. M., and Jordan, L. G., Jr. Surgery of the liver. In "Diseases of the Liver," (L. Schiff,
Ed.), Chap. 25, pp. 864-923. J. P. Lippincott Co., Philadelphia, 1969.
24. Groszmann, R. J., Kotelanski, B., and Cohn, J. N. Hepatic lobar distribution of splenic and
mesenteric blood flow in man. Gastroenterology 60, 1047-1052 (1971).
25. Huet, P. M., Lavoie, P., and Viallet, A. Sinusoidal fraction ofportal blood flow: estimation by a mul-
tiple indicator dilution method in dogs (abstract). Gastroenterology 65, 547 (1973).
26. Shackman, R., Graber, I. G., Melrose, D. G. Liver blood flow and general anaesthesia. Clin. Sci. 12,
307-315 (1953).
27. Mikkelsen, W. P. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid
effects ofacutehyaline necrosis. Arch. Surg. 108, 302-305 (1974).
28. Read, A. E., Laidlaw, J., and Sherlock, S. Neuropsychiatric complications of portacaval
anastomosis. Lancet 1, 961-963 (1961).
29. Warren, W. D., Restrepo, J. E., Respess, J. C., Muller, W. H. The importance of hemodynamic
studies in the management ofportal hypertension. Ann. Surg. 158, 387-404 (1963).
30. Reynolds, T. B. Hepatic circulatory changes after shunt surgery. Ann. N. Y. Acad. Sci. 170, 379-391
(1970).
31. Burchell, A. R., Moreno, A. H., Panke, W. F., and Nealon, T. F. Hemodynamic variables and prog-
nosis following portacaval shunts.Surg. Gynecol. Obstet. 138, 359-369 (1974).
32. Maillard, J. N., Rueff, B., Prandi, D., and Sicot, C. Hepatic arterialization and portacaval shunt in
hepatic cirrhosis. Arch. Surg. 108, 315-320 (1974).